IBD therapeutics (Amgen/DGT)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameIBD therapeutics (Amgen/DGT)
Drug Alias NameIBD therapeutics (Immenex/DGT)inflammatory bowel disease therapeutics (Amgen/DGT)inflammatory bowel disease therapeutics (Immenex/DGT)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsInflammationInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImmunex Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDigital Gene Technologies IncAmgen IncImmunex Corp
Active IndicationsN/A
Inactive IndicationsInflammationInflammatory Bowel Diseases

Other Information

ATC CodeN/A
Related LinksN/A